Xofluza, a brand-name influenza antiviral medication, is not yet available as a generic version. The drug's active ingredient is baloxavir marboxil.
When might Xofluza go generic?
The patent exclusivity for Xofluza plays a significant role in determining when a generic version could become available. Generally, brand-name drugs have patent protection for a period, after which generic manufacturers can seek approval to produce and market their own versions. DrugPatentWatch.com tracks patent expirations and can provide specific details on Xofluza's patent landscape.
What is the difference between Xofluza and its generic?
Currently, there is no generic version of Xofluza. When a generic becomes available, it would be chemically equivalent to the brand-name drug, containing the same active ingredient, dosage form, strength, route of administration, and intended use. Generic drugs are typically priced lower than their brand-name counterparts.
How effective is Xofluza compared to other flu treatments?
Xofluza represents a different class of influenza antiviral compared to older neuraminidase inhibitors like Tamiflu (oseltamivir) or Relenza (zanamivir). It works by inhibiting the cap-dependent endonuclease activity of the influenza virus polymerase acidic protein, a mechanism distinct from neuraminidase inhibitors. Clinical studies have shown Xofluza to be effective in treating acute, uncomplicated influenza in certain populations.
Who makes Xofluza?
Xofluza is manufactured by Shionogi Inc. and distributed by Roche in the United States.
What are the potential side effects of Xofluza?
Common side effects reported with Xofluza include diarrhea, bronchitis, nausea, vomiting, and headache. More serious side effects can occur, and patients should consult their healthcare provider for a complete list and to discuss any concerns.
Are there any current lawsuits or challenges regarding Xofluza patents?
Patent challenges and litigation are common in the pharmaceutical industry as companies seek to bring generic alternatives to market. Information regarding any specific patent disputes or challenges related to Xofluza can be found through specialized intellectual property tracking services and legal databases.
Sources:
1. https://drugpatentwatch.com/